✦ LIBER ✦

Randomized phase 2 study of irinotecan plus cisplatin versus gemcitabine plus vinorelbine as first-line chemotherapy with second-line crossover in patients with advanced nonsmall cell lung cancer

✍ Scribed by Ji-Youn Han; Dae Ho Lee; Jung Eun Song; Sung Young Lee; Hyae Young Kim; Heung Tae Kim; Jin Soo Lee

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 145 KB
Volume: 113
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.23582

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized phase II trial of two differe

Randomized phase II trial of two different schedules of docetaxel plus cisplatin as first-line therapy in advanced nonsmall cell lung cancer

✍ Se Hoon Park; Soo Jin Choi; Sun Young Kyung; Chang Hyeok An; Sang Pyo Lee; Jeong 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

Elderly subgroup analysis of a randomize

Elderly subgroup analysis of a randomized phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for first-line treatment of advanced nonsmall cell lung carcinoma (TAX 326)

✍ Chandra P. Belani; Frank Fossella 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 2 views

A multicenter, randomized, Phase II stud

A multicenter, randomized, Phase II study of cisplatin, etoposide, and gemcitabine or cisplatin plus gemcitabine as first-line treatment in patients with poor-prognosis small cell lung carcinoma

✍ Filippo De Marinis; Fabrizio Nelli; Marco Lombardo; Francesco Ferraú; Santi Barb 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this study was to evaluate the activity and toxicity of combined cisplatin, etoposide, and gemcitabine (PEG) and combined cisplatin plus gemcitabine (PG) in previously untreated patients with extensive‐stage and poor‐prognosis limited‐stage small‐cell lun

Randomized phase II study of carboplatin

Randomized phase II study of carboplatin/gemcitabine versus vinorelbine/gemcitabine in patients with advanced nonsmall cell lung cancer : West Japan Thoracic Oncology Group (WJTOG) 0104

✍ Nobuyuki Yamamoto; Kazuhiko Nakagawa; Hisao Uejima; Takahiko Sugiura; Yoshiki Ta 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB

Prognostic influence of metformin as fir

Prognostic influence of metformin as first-line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes

✍ Ben-Xu Tan; Wen-Xiu Yao; Jun Ge; Xing-Chen Peng; Xiao-Bo Du; Ru Zhang; Bin Yao; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 260 KB 👁 3 views

Weekly docetaxel with either gemcitabine

Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma : Phase II trials of the Minnie Pearl Cancer Research Network

✍ John D. Hainsworth; Howard A. Burris III; Frederic T. Billings III; James E. Bra 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 3 views